Ligand · IWR
IWR · 4-[(3aR,4S,7R,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]-N-(quinolin-8-yl)benzamide
IWR, 4-[(3aR,4S,7R,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]-N-(quinolin-8-yl)benzamide (C25 H19 N3 O3, 409.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- IWR
- Formula
- C25 H19 N3 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
IWR in 2 structures; the first of them:
- 3UA9 · Crystal structure of human tankyrase 2 in complex with a selective inhibitor · IWR A2 · binds HIS1031, GLY1032, SER1033, PHE1035, ALA1038, ILE1039, LYS1042, GLY1043 and 10 more
- 3UA9 · Crystal structure of human tankyrase 2 in complex with a selective inhibitor · IWR A2 · binds HIS1031, GLY1032, SER1033, PHE1035, ALA1038, ILE1039, LYS1042, GLY1043 and 10 more
Residues it binds most
GLY 4, ILE 4, TYR 4, ALA 4, HIS 4, PHE 4, ASP 4, SER 4, LYS 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.